CompoAtlas

新-貝爾葉黃素軟膠囊

新-貝爾葉黃素軟膠囊 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Registration number
1056042681
Chinese name
新-貝爾葉黃素軟膠囊
English name
NEW BEAR LUTEIN SOFTGEL
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
昆昱國際有限公司
Registration date
2016-10-12
Published validity end
2026-10-12

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
SHARK LIVER OILSHARK LIVER OILNot identified
SALMON OILSALMON OILHuile de saumon
EYEBRIGHT EXTRACTEYEBRIGHT EXTRACTNot identified
MALTODEXTRINMALTODEXTRINMaltodextrine
COLLOIDAL ANHYDROUS SILICACOLLOIDAL ANHYDROUS SILICANot identified
LYCII FRUCTUSLYCII FRUCTUSNot identified
BLUEBERRY POWDERBLUEBERRY POWDERNot identified
SNAKE GALLSNAKE GALLNot identified
LUTEINLUTEINNot identified
TAURINETAURINETaurine
LECITHINLECITHINNot identified
BILBERRY EXTRACTBILBERRY EXTRACTNot identified
PAPAYA ENZYMESPAPAYA ENZYMESNot identified
β-CAROTENEβ-CAROTENEBêta-carotène
VITAMIN D3 (CHOLECALCIFEROL)VITAMIN D3 (CHOLECALCIFEROL)Vitamine D
GELATINGELATINNot identified
GLYCERINGLYCERINNot identified
PURIFIED WATERPURIFIED WATERNot identified
TITANIUM DIOXIDETITANIUM DIOXIDENot identified
FD & C RED #40FD & C RED #40Not identified
FD & C RED #3FD & C RED #3Not identified
FD & C YELLOW #5FD & C YELLOW #5Not identified
FD & C YELLOW #6FD & C YELLOW #6Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Product name
新-貝爾葉黃素軟膠囊
Active ingredients
SHARK LIVER OIL;;SALMON OIL;;EYEBRIGHT EXTRACT;;MALTODEXTRIN;;COLLOIDAL ANHYDROUS SILICA;;LYCII FRUCTUS;;BLUEBERRY POWDER;;SNAKE GALL;;LUTEIN;;TAURINE;;LECITHIN;;BILBERRY EXTRACT;;PAPAYA ENZYMES;;β-CAROTENE;;VITAMIN D3 (CHOLECALCIFEROL);;GELATIN;;GLYCERIN;;PURIFIED WATER;;TITANIUM DIOXIDE;;FD & C RED #40;;FD & C RED #3;;FD & C YELLOW #5;;FD & C YELLOW #6;;
Valid until
1151012
Registration number
1056042681
Licence holder
昆昱國際有限公司
Registration date
1051012
Published reference
DHC0A560426810
Published English name
NEW BEAR LUTEIN SOFTGEL

Official source

View the official register, number 1056042681

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • TAURINE
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • VITAMIN D3 (CHOLECALCIFEROL)
    Read the warning, when it applies and the studies cited

    VITAMIN D (>1,000 - 2,500 IU)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Applies to products containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 June 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line